Peripheral Neuropathy
Reference List

1. Argyriou, A.A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoul, G., Iconomou, G., & Kalofonos, H.P. (2005). Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology, 64, , 26-31.
2. Armstrong, T., Almadrones, L., & Gilbert, M.R. (2005). Chemotherapy-induced Peripheral neuropathy. Oncology Nursing Forum, 32,, 305-311.
3. Brant, J.M. (1998). Cancer-related neuropathic pain, Nurse Practice Forum, 9, , 154-162.
4. Cascinu, S., Cordella, L., Del Ferro, E., Fronzoni, M., Catalano, G. (1995). Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled trial. Journal of Clinical Oncology, 13(1), 26-32.
5. Caveletti, G. & Zanna, C. (2002). Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. European Journal of Cancer, 38, , 1832-1837.
6. Decker, G.M. (2002). Glutamine: indicated in cancer care? Clinical Journal of Oncology Nursing, 6, 112-115.
7. Freynhagen, R. Strojek, K., Griesing, T, Whalen, E. & Balkenohl, M. (2005). Efficacy of Pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blinded, multicentre, placebo-controlled trial of flexible- and fixed-dose Regimens. Pain, 115, , 254-263.
8. Galer, B.S. & Dworkin, R.H. (2000). A clinical guide to neuropathic pain. Philadelphia:The McGraw-Hill Companies.
9. Gilron, I., Bailey, J.M., Dongsheng, T., Holden, R.R., Weaver, D.F., & Houlden, R.L. (2005). Morphine, gabapentin, or their combination for neuropathic pain. , The New England Journal of Medicine, 352, , 1324-1334.
10. Grothey, A. (2003). Oxaliplatin-safety profile: neurotoxicity. Seminars in Oncology On-line, 30(Supl. 15), Retrieved June 20, 2005,
11. www2.us.elsevierhealth.com/scripts/om.dll/serve?retrieve=/pii/S0093775403003993.
12. Hughes, R.A. (2002). Peripheral neuropathy, British Medical Journal, 324, , 466-469.
13. Kanat, O., Evrensel, T., Baran, I., Coskun, H., Zarifogul, M., Turan, O.F., Kurt Demiray, M., Gonullu, G., & Manavoglu, O. (2003). Protective effect of amifostine against paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study. Medical Oncology, 20, , 237-245.
14. Kemp, G., Rose, Pl, Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley Belpomme, D., & Glick, J. (1996). Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. Journal of Clinical Oncology, 14, , 2101-2112.
15. Lorusso, D., Ferrandina, G., Greggi, S., Gadducci, A., Pignata, S., Tateo, S., Biamonte,R., Manzione, L., DiVagno, G., Ferrau’, F., & Scambia, G. (2003). Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Annals of Oncology, 14, , 1086-1093.
16. Ocean, A.J. & Vahdat, L.T. (2004). Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Supportive Care in Cancer, 12, 619-625.
17. Ohio State University Medical Center (2005). Peripheral Neuropathy Related to Cancer and Cancer Treatment Guidelines. Retrieved January 15, 2005. http://medicalcenter.osu.edu/patientcare/healthinformation/education/index.cfm.
18. Raja, S.N. & Haythornthwaite, J.A. (2005). Combination therapy for neuropathic pain- Which drugs, which combination, which patients? The New England Journal of Medicine, 35, 1373-1375.
19. Savarese, D.M., Savy, G., Vahdat, L., Wischmeyer, P.E., & Corey, B. (2003). Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treatment Review, 29, , 501-513.
20. Sindrup, S.H. & Jensen, T.S. (2000). Pharmacologic treatment of pain in polyneuropathy, Neurology, 55, 915-920.
21. Wilkes, G.M. (2004). Peripheral neuropathy, In Cancer Symptom Management, , (C.H. Yarbro, M.H. Frogge, & M.Goodman, Eds.).pp. 333-358. Boston: Jones and Bartlett Publishers.
22. Vahdat, L., Papadopoulos, K., Lange, D., Leuin, S., Kaufman, E., Donovan, D., Frederick, D., Bagiella, E., Hesdorffer, C.S., & Balmaceda, C. (2001). Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clinical Cancer Research, 7, , 1192-1197.
23. Verstappen, C.C., Postma, T.J., Geldof, A.A., & Heimans, J.J. (2004). Amifostine protects against chemotherapy-induced neurotoxicity an in vitro investigation. Anticancer Research, 24, , 2337-2341.
24. Visovsky, C. (2003). Chemotherapy-induced peripheral neuropathy. Cancer Investigation, 21(3), 439-451.